Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37,000
Closed -$1.5M 1285
2022
Q4
$1.5M Buy
+37,000
New +$1.96M 0.01% 806

Other funds holding CRSP

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's CRSP Position: Q1 2023 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold out of CRISPR Therapeutics (CRSP) in Q1 2023, closing a stake of 37,000 shares — an estimated $1.5M sold.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in CRSP in Q4 2022 and held it in 1 quarter. The position peaked at $1.5M in Q4 2022. 381 funds tracked by Wall St. Rank hold CRSP as of Q1 2023.

  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund reported no remaining CRISPR Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold 37,000 CRISPR Therapeutics shares in Q1 2023, an estimated $1.5M.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in CRISPR Therapeutics in Q4 2022 and held it in 1 quarter.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's CRISPR Therapeutics position peaked at $1.5M in Q4 2022.
  • 381 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2023.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q1 2023, filed 12 May 2023.